tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARGX Stock Latest News

Argenx Halts Phase 3 Thyroid Eye Disease Trial: Clinical Setback With Focused Market Impact
Company AnnouncementsArgenx Halts Phase 3 Thyroid Eye Disease Trial: Clinical Setback With Focused Market Impact
13h ago
ARGX
Argenx Ends Phase 3 Thyroid Eye Disease Trial, Resetting Expectations for Efgartigimod
PremiumCompany Announcements
Argenx Ends Phase 3 Thyroid Eye Disease Trial, Resetting Expectations for Efgartigimod
13h ago
ARGX
Argenx’s Long‑Term ITP Study Reaches Completion, Sharpening the Outlook for Efgartigimod
PremiumCompany Announcements
Argenx’s Long‑Term ITP Study Reaches Completion, Sharpening the Outlook for Efgartigimod
13h ago
ARGX
Argenx upgraded to Buy from Hold at Deutsche Bank
PremiumThe Fly
Argenx upgraded to Buy from Hold at Deutsche Bank
6d ago
ARGX
Deutsche Bank upgrades Argenx on Vyvgart momentum, less-demanding valuation
PremiumThe Fly
Deutsche Bank upgrades Argenx on Vyvgart momentum, less-demanding valuation
6d ago
ARGX
Argenx Opens Phase 1 Safety Trial for ARGX-124, Expanding Its Pipeline Potential
PremiumCompany AnnouncementsArgenx Opens Phase 1 Safety Trial for ARGX-124, Expanding Its Pipeline Potential
11d ago
ARGX
Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting
Premium
Company Announcements
Argenx Unveils New VYVGART and Neurology Pipeline Data Ahead of 2026 AAN Meeting
11d ago
6K
ARGX
Argenx Earnings Call Highlights Explosive Growth, Ocular Win
Premium
Company Announcements
Argenx Earnings Call Highlights Explosive Growth, Ocular Win
15d ago
ARGX
Argenx price target lowered to $890 from $925 at RBC Capital
PremiumThe Fly
Argenx price target lowered to $890 from $925 at RBC Capital
18d ago
ARGX
Argenx price target lowered to $890 from $925 at RBC Capital
PremiumThe Fly
Argenx price target lowered to $890 from $925 at RBC Capital
18d ago
ARGX
Argenx price target raised to $867 from $858 at Baird
PremiumThe Fly
Argenx price target raised to $867 from $858 at Baird
18d ago
ARGX
Argenx price target lowered to $1,120 from $1,160 at Guggenheim
PremiumThe Fly
Argenx price target lowered to $1,120 from $1,160 at Guggenheim
18d ago
ARGX
Argenx price target lowered to $1,247 from $1,317 at Wells Fargo
PremiumThe FlyArgenx price target lowered to $1,247 from $1,317 at Wells Fargo
18d ago
ARGX
Argenx price target raised to $940 from $915 at H.C. Wainwright
Premium
The Fly
Argenx price target raised to $940 from $915 at H.C. Wainwright
18d ago
ARGX
Argenx price target raised to $944 from $925 at Citizens
Premium
The Fly
Argenx price target raised to $944 from $925 at Citizens
18d ago
ARGX
Argenx price target lowered to $1,227 from $1,248 at Stifel
PremiumThe Fly
Argenx price target lowered to $1,227 from $1,248 at Stifel
19d ago
ARGX
Vyvgart’s Strengthening MG Franchise and Pipeline Catalysts Support Buy Rating on Argenx
PremiumRatings
Vyvgart’s Strengthening MG Franchise and Pipeline Catalysts Support Buy Rating on Argenx
19d ago
ARGX
Argenx Posts First Operating Profit on Surging VYVGART Sales and Expanding Autoimmune Pipeline
PremiumCompany Announcements
Argenx Posts First Operating Profit on Surging VYVGART Sales and Expanding Autoimmune Pipeline
19d ago
6K
ARGX
Argenx Reports Positive Phase 3 VYVGART Data in Ocular Myasthenia Gravis
PremiumCompany Announcements
Argenx Reports Positive Phase 3 VYVGART Data in Ocular Myasthenia Gravis
19d ago
6K
ARGX
Argenx announces ADAPT OCULUS study met primary endpoint
PremiumThe FlyArgenx announces ADAPT OCULUS study met primary endpoint
19d ago
ARGX
Argenx reports Q4 EPS $8.02 vs. $11.79 last year
Premium
The Fly
Argenx reports Q4 EPS $8.02 vs. $11.79 last year
19d ago
ARGX
Argenx (ARGX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Argenx (ARGX) Q4 Earnings Cheat Sheet
21d ago
ARGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >